BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pharma Journalist
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200622
DTEND;VALUE=DATE:20200625
DTSTAMP:20260515T093609
CREATED:20191022T082827Z
LAST-MODIFIED:20191022T093157Z
UID:22997-1592784000-1593043199@www.pharmajournalist.com
SUMMARY:CPhI & P-MEC China 2020
DESCRIPTION:CPhI & P-MEC China is your gateway to successfully grow your business at the 2nd largest pharma market in the world and your ONE-STOP SHOP pharmaceutical platform connecting the entire pharmaceutical industry chain. On 22-24 June 2020\, CPhI China 2020\, collocated with ICSE China\, NEX China\, and P-MEC China\, will continue its glorious journey and celebrate its 20th anniversary at Shanghai New International Exhibition Centre (SNIEC). The show is to cover an exhibition area of 210\,000 sqm and is expected to draw 3\,400+ exhibitors from over 140 countries and regions and 75\,000+ visits from global industry professionals. \nTo learn more about CPhI & P-MEC China and to register online\, visit www.cphi-china.cn/en
URL:https://www.pharmajournalist.com/event/cphi-p-mec-china-2020/
LOCATION:Shanghai New Int’l Expo Centre (SNIEC)\, 2345 Longyang Road\, Shanghai\, China
ORGANIZER;CN="Informa Markets%2C CCCMHPIE%2C Sinoexpo Informa Markets":MAILTO:yingqi.shi@imsinoexpo.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200624
DTEND;VALUE=DATE:20200625
DTSTAMP:20260515T093609
CREATED:20200515T080714Z
LAST-MODIFIED:20200515T080714Z
UID:25507-1592956800-1593043199@www.pharmajournalist.com
SUMMARY:JAK Inhibitors Drug Development Summit – Running Digitally for 2020
DESCRIPTION:Despite the increasingly unpredictable nature of COVID-19\, our commitment to provide educational resources and networking experiences to keep pharmaceutical knowledge thriving and the industry moving forward has not wavered. \n \nTherefore\, we are very excited to announce that the JAK Inhibitors Drug Development Summit has been transformed into an exclusive one-day digital event that will immerse you in discussions on developing the next generation of JAK inhibitors to expand their clinical utility across oncology\, dermatology and autoimmune disease indications. \nThis is your one and only cross-disciplinary JAK inhibitor meeting with all the content and networking opportunities now delivered in a digital format. \nOur community of JAK inhibitor experts are looking forward to connecting with you in the digital world\, including: \n\nLeandro Santos\, Associate Director\, Clinical Sciences Incyte\nMaciej Wieczorek\, Chief Executive Officer\, Celon Pharma\nPiet Wigerinck\, Chief Scientific Officer\, Galapagos\nAnabela Cardoso\, Global Brand Development\, Lead – Immunology\, Eli Lilly\nBrett King\, Associate Professor of Dermatology\, Yale School of Medicine\nMassimo Gadina\, Chief Translational Immunology Section\, National Institute of Arthritis & Musculoskeletal & Skin Diseases\n\nDon’t miss this opportunity to hear about the latest data shared by peers\, and take advantage of the online networking and ‘Ask the Expert Speaker’ chatrooms. \nVisit the website to learn more and secure your place: https://ter.li/o6ghqw
URL:https://www.pharmajournalist.com/event/jak-inhibitors-drug-development-summit-running-digitally-for-2020/
LOCATION:Online
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR